FOXM1 plays a role in autophagy by transcriptionally regulating Beclin-1 and LC3 genes in human triple-negative breast cancer cells

Triple-negative breast cancer (TNBC) is associated with poor prognosis owing to its aggressive and heterogeneous nature, and the lack of therapeutic targets. Although Forkhead Box M1 (FOXM1) is one of the most important oncogenes contributing to tumorigenesis, progression, and drug resistance in TNB...

Full description

Saved in:
Bibliographic Details
Published in:Journal of molecular medicine (Berlin, Germany) Vol. 97; no. 4; pp. 491 - 508
Main Authors: Hamurcu, Zuhal, Delibaşı, Nesrin, Nalbantoglu, Ufuk, Sener, Elif Funda, Nurdinov, Nursultan, Tascı, Bayram, Taheri, Serpil, Özkul, Yusuf, Donmez-Altuntas, Hamiyet, Canatan, Halit, Ozpolat, Bulent
Format: Journal Article
Language:English
Published: Berlin/Heidelberg Springer Berlin Heidelberg 01-04-2019
Springer Nature B.V
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Triple-negative breast cancer (TNBC) is associated with poor prognosis owing to its aggressive and heterogeneous nature, and the lack of therapeutic targets. Although Forkhead Box M1 (FOXM1) is one of the most important oncogenes contributing to tumorigenesis, progression, and drug resistance in TNBC, the underlying molecular mechanisms are not well understood. Emerging evidence indicates that autophagy plays a critical role in cell survival and protective mechanism in TNBC. However, signaling pathways that are involved in the regulation of autophagy remain to be elucidated. In the present study, we examined the role of FOXM1 in regulating autophagy in TNBC cells and found that FOXM1 is upregulated during induction of autophagy. We found that inhibition of FOXM1 suppressed starvation and rapamycin-induced autophagy and expression of the major autophagy regulators, LC3 and Beclin-1. Further studies demonstrated that FOXM1 directly binds to the promotors of LC3 and Beclin-1 genes and transcriptionally regulates their expression by chromatin immunoprecipitation (ChIP) and luciferase gene reporter assays. In conclusion, our study provides the first evidence about the role of FOXM1 in regulating expression of LC3 and Beclin-1 and autophagy in TNBC cells. Our findings provide novel insight into the role of FOXM1 regulation of the autophagic survival pathway and potential molecular target for treating TNBC. Key messages • FOXM1 promotes tumorigenesis and progression of TNBC. However, the underlying molecular mechanism by which FOXM1 promotes TNBC tumorigenesis is unclear. The goal of our study was to determine the role of FOXM1 in the regulation of autophagy that plays a role in TNBC progression. Our findings show that FOXM1 binds to promoters of the genes encoding the major autophagy proteins, Beclin and LC3, and provide new insights into the regulation of autophagy, which is being targeted in many clinical trials.
AbstractList Triple-negative breast cancer (TNBC) is associated with poor prognosis owing to its aggressive and heterogeneous nature, and the lack of therapeutic targets. Although Forkhead Box M1 (FOXM1) is one of the most important oncogenes contributing to tumorigenesis, progression, and drug resistance in TNBC, the underlying molecular mechanisms are not well understood. Emerging evidence indicates that autophagy plays a critical role in cell survival and protective mechanism in TNBC. However, signaling pathways that are involved in the regulation of autophagy remain to be elucidated. In the present study, we examined the role of FOXM1 in regulating autophagy in TNBC cells and found that FOXM1 is upregulated during induction of autophagy. We found that inhibition of FOXM1 suppressed starvation and rapamycin-induced autophagy and expression of the major autophagy regulators, LC3 and Beclin-1. Further studies demonstrated that FOXM1 directly binds to the promotors of LC3 and Beclin-1 genes and transcriptionally regulates their expression by chromatin immunoprecipitation (ChIP) and luciferase gene reporter assays. In conclusion, our study provides the first evidence about the role of FOXM1 in regulating expression of LC3 and Beclin-1 and autophagy in TNBC cells. Our findings provide novel insight into the role of FOXM1 regulation of the autophagic survival pathway and potential molecular target for treating TNBC. KEY MESSAGES: • FOXM1 promotes tumorigenesis and progression of TNBC. However, the underlying molecular mechanism by which FOXM1 promotes TNBC tumorigenesis is unclear. The goal of our study was to determine the role of FOXM1 in the regulation of autophagy that plays a role in TNBC progression. Our findings show that FOXM1 binds to promoters of the genes encoding the major autophagy proteins, Beclin and LC3, and provide new insights into the regulation of autophagy, which is being targeted in many clinical trials.
Triple-negative breast cancer (TNBC) is associated with poor prognosis owing to its aggressive and heterogeneous nature, and the lack of therapeutic targets. Although Forkhead Box M1 (FOXM1) is one of the most important oncogenes contributing to tumorigenesis, progression, and drug resistance in TNBC, the underlying molecular mechanisms are not well understood. Emerging evidence indicates that autophagy plays a critical role in cell survival and protective mechanism in TNBC. However, signaling pathways that are involved in the regulation of autophagy remain to be elucidated. In the present study, we examined the role of FOXM1 in regulating autophagy in TNBC cells and found that FOXM1 is upregulated during induction of autophagy. We found that inhibition of FOXM1 suppressed starvation and rapamycin-induced autophagy and expression of the major autophagy regulators, LC3 and Beclin-1. Further studies demonstrated that FOXM1 directly binds to the promotors of LC3 and Beclin-1 genes and transcriptionally regulates their expression by chromatin immunoprecipitation (ChIP) and luciferase gene reporter assays. In conclusion, our study provides the first evidence about the role of FOXM1 in regulating expression of LC3 and Beclin-1 and autophagy in TNBC cells. Our findings provide novel insight into the role of FOXM1 regulation of the autophagic survival pathway and potential molecular target for treating TNBC. Key messages • FOXM1 promotes tumorigenesis and progression of TNBC. However, the underlying molecular mechanism by which FOXM1 promotes TNBC tumorigenesis is unclear. The goal of our study was to determine the role of FOXM1 in the regulation of autophagy that plays a role in TNBC progression. Our findings show that FOXM1 binds to promoters of the genes encoding the major autophagy proteins, Beclin and LC3, and provide new insights into the regulation of autophagy, which is being targeted in many clinical trials.
Author Sener, Elif Funda
Taheri, Serpil
Delibaşı, Nesrin
Nurdinov, Nursultan
Donmez-Altuntas, Hamiyet
Nalbantoglu, Ufuk
Özkul, Yusuf
Ozpolat, Bulent
Canatan, Halit
Hamurcu, Zuhal
Tascı, Bayram
Author_xml – sequence: 1
  givenname: Zuhal
  surname: Hamurcu
  fullname: Hamurcu, Zuhal
  organization: Faculty of Medicine, Department of Medical Biology, Erciyes University, Betül-Ziya Eren Genome and Stem Cell Center, Erciyes University, Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center
– sequence: 2
  givenname: Nesrin
  surname: Delibaşı
  fullname: Delibaşı, Nesrin
  organization: Faculty of Medicine, Department of Medical Biology, Erciyes University, Betül-Ziya Eren Genome and Stem Cell Center, Erciyes University
– sequence: 3
  givenname: Ufuk
  surname: Nalbantoglu
  fullname: Nalbantoglu, Ufuk
  organization: Betül-Ziya Eren Genome and Stem Cell Center, Erciyes University, Faculty of Engineering, Department of Computer Engineering, Bioinformatics, Genome and Stem Cell Center
– sequence: 4
  givenname: Elif Funda
  surname: Sener
  fullname: Sener, Elif Funda
  organization: Faculty of Medicine, Department of Medical Biology, Erciyes University, Betül-Ziya Eren Genome and Stem Cell Center, Erciyes University
– sequence: 5
  givenname: Nursultan
  surname: Nurdinov
  fullname: Nurdinov, Nursultan
  organization: Faculty of Medicine, Department of Medical Biology, Erciyes University, Betül-Ziya Eren Genome and Stem Cell Center, Erciyes University
– sequence: 6
  givenname: Bayram
  surname: Tascı
  fullname: Tascı, Bayram
  organization: Betül-Ziya Eren Genome and Stem Cell Center, Erciyes University, Medical Faculty, Erciyes University
– sequence: 7
  givenname: Serpil
  surname: Taheri
  fullname: Taheri, Serpil
  organization: Faculty of Medicine, Department of Medical Biology, Erciyes University, Betül-Ziya Eren Genome and Stem Cell Center, Erciyes University
– sequence: 8
  givenname: Yusuf
  surname: Özkul
  fullname: Özkul, Yusuf
  organization: Betül-Ziya Eren Genome and Stem Cell Center, Erciyes University, Faculty of Medicine, Department of Medical Genetics, Erciyes University
– sequence: 9
  givenname: Hamiyet
  surname: Donmez-Altuntas
  fullname: Donmez-Altuntas, Hamiyet
  organization: Faculty of Medicine, Department of Medical Biology, Erciyes University
– sequence: 10
  givenname: Halit
  surname: Canatan
  fullname: Canatan, Halit
  organization: Faculty of Medicine, Department of Medical Biology, Erciyes University
– sequence: 11
  givenname: Bulent
  surname: Ozpolat
  fullname: Ozpolat, Bulent
  email: bozpolat@mdanderson.org
  organization: Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30729279$$D View this record in MEDLINE/PubMed
BookMark eNp9kT1v1TAUhi1URG8Lf4ABWWJhMRw7H05GuKIt0kVdQGKzTpyTNJWvE-ykUmb-OA63gMTAYHnw874-9nPBzvzoibGXEt5KAP0uAkioBcht6QJE9YTtZJ4pIfMcztgO6rwUSsvynF3EeA8bVefP2HkGWtVK1zv24-r222fJJ4dr5MjD6IgPnuMyj9Md9itvVj4H9NGGYZqH0aNzKw_ULw7nwff8A1k3eCE5-pYf9hnvyVPcOu6WI_oUHiZHwlOf-AfiTSCMM7foLQVuybn4nD3t0EV68bhfsq9XH7_sb8Th9vrT_v1B2EwXs-i6rmqqQjZWFpLa0qKiti41QQ05yaqkApS0GeYZ1EVlmwYLSxViCbZqrc0u2ZtT7xTG7wvF2RyHuE2AnsYlGqXSr2qlSp3Q1_-g9-MS0uMTJbUGWeoiT5Q6UTaMMQbqzBSGI4bVSDCbInNSZJIi80uRqVLo1WP10hyp_RP57SQB2QmI6cj3FP7e_Z_an2Kuno0
CitedBy_id crossref_primary_10_1016_j_cellsig_2021_109979
crossref_primary_10_1186_s12859_021_04503_y
crossref_primary_10_1007_s12282_022_01391_9
crossref_primary_10_2174_1568009623666221228104833
crossref_primary_10_3389_fgene_2021_569318
crossref_primary_10_1007_s11033_022_07536_5
crossref_primary_10_1002_slct_202304893
crossref_primary_10_1007_s12035_023_03609_z
crossref_primary_10_1016_j_apsb_2023_08_008
crossref_primary_10_3390_ijms232415699
crossref_primary_10_12677_ACM_2023_131010
crossref_primary_10_3390_cancers11040507
crossref_primary_10_2174_1871520620666200807221047
crossref_primary_10_1080_14728222_2020_1727888
crossref_primary_10_1016_j_canlet_2019_11_014
crossref_primary_10_2174_1871520620666200619180716
crossref_primary_10_2139_ssrn_3970999
crossref_primary_10_1007_s11033_022_07751_0
crossref_primary_10_1007_s11011_022_01125_y
crossref_primary_10_1007_s12032_024_02427_0
crossref_primary_10_1038_s41397_022_00297_1
crossref_primary_10_1007_s00408_022_00569_4
crossref_primary_10_36660_abc_20220479
crossref_primary_10_1016_j_lfs_2021_119042
crossref_primary_10_1080_14728222_2023_2177151
crossref_primary_10_1007_s11010_021_04063_y
crossref_primary_10_1038_s41418_023_01193_2
crossref_primary_10_1080_08941939_2020_1852344
crossref_primary_10_1093_molehr_gaab030
crossref_primary_10_3390_ijms241813985
crossref_primary_10_1186_s13046_022_02390_6
crossref_primary_10_3389_fonc_2020_626836
Cites_doi 10.1186/s12885-017-3939-4
10.15252/emmm.201708799
10.1007/s00018-018-2759-2
10.1007/s10549-017-4207-7
10.5483/BMBRep.2016.49.8.081
10.1093/abbs/gmv119
10.1111/iep.12187
10.1080/15548627.2015.1100356
10.3892/br.2017.915
10.1002/1873-3468.12594
10.1128/MCB.25.24.10875-10894.2005
10.1016/S0014-5793(01)02915-5
10.2147/CMAR.S34859
10.1016/B978-0-12-407173-5.00004-2
10.1093/jjco/hyt160
10.1038/s41580-018-0003-4
10.1016/j.semcancer
10.1371/journal.pone.0041171
10.3390/cancers9120162
10.3389/fonc.2016.00236
10.1038/onc.2009.282
10.1038/nature11412
10.1007/s12032-013-0475-1
10.1016/j.breast.2017.06.043
10.1007/s10549-016-3904-y
10.1007/s12032-017-0888-3
10.3390/biom8020014
10.1111/his.12002
10.1111/cpr.12402
10.1007/s12192-014-0545-0
10.18632/oncotarget.7672
10.1615/CritRevOncog.2017020575
10.1016/j.canlet.2012.09.017
10.3390/cancers10010018
10.1155/2016/9768183
10.4161/15548627.2014.981788
10.1158/0008-5472.CAN-16-3566
10.1371/journal.pone.0144241
10.1038/sj.bjc.6690012
10.1016/j.ajpath.2013.05.033
10.1097/CAD.0000000000000564
10.4161/15384047.2014.987566
10.1007/s00432-017-2557-5
10.1038/mtna.2013.45
10.18632/oncotarget.23182
ContentType Journal Article
Copyright Springer-Verlag GmbH Germany, part of Springer Nature 2019
Journal of Molecular Medicine is a copyright of Springer, (2019). All Rights Reserved.
Copyright_xml – notice: Springer-Verlag GmbH Germany, part of Springer Nature 2019
– notice: Journal of Molecular Medicine is a copyright of Springer, (2019). All Rights Reserved.
DBID NPM
AAYXX
CITATION
3V.
7TK
7X7
7XB
88E
8AO
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FYUFA
GHDGH
K9.
M0S
M1P
PQEST
PQQKQ
PQUKI
PRINS
7X8
DOI 10.1007/s00109-019-01750-8
DatabaseName PubMed
CrossRef
ProQuest Central (Corporate)
Neurosciences Abstracts
Health & Medical Collection (Proquest)
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central
ProQuest One Community College
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
DatabaseTitle PubMed
CrossRef
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
Neurosciences Abstracts
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList PubMed
ProQuest One Academic Eastern Edition

DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1432-1440
EndPage 508
ExternalDocumentID 10_1007_s00109_019_01750_8
30729279
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation_xml – fundername: The Scientific and Technological Research Council ?T?B?TAK, Research Fund of the Erciyes University
  grantid: T?B?TAK- research grant (grant number 214S204) and The Erciyes University (Project number: TDA-2016-6415).
GroupedDBID ---
-4W
-56
-5G
-BR
-EM
-~C
.86
.VR
06C
06D
0R~
0VY
199
1N0
203
29L
29~
2J2
2JN
2JY
2KG
2KM
2LR
2~H
30V
36B
4.4
406
408
409
40D
40E
5GY
5RE
5VS
67N
67Z
6NX
78A
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AAFGU
AAHNG
AAIAL
AAJKR
AANZL
AARTL
AATNV
AATVU
AAUYE
AAWCG
AAYFA
AAYIU
AAYQN
ABBBX
ABBXA
ABDZT
ABECU
ABFGW
ABFTV
ABHLI
ABHQN
ABJOX
ABKAS
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABOCM
ABPLI
ABPTK
ABQBU
ABSXP
ABTEG
ABTHY
ABTKH
ABTMW
ABUWG
ABWNU
ABXPI
ACBMV
ACBRV
ACBYP
ACGFS
ACHSB
ACHXU
ACIGE
ACIPQ
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACTTH
ACVWB
ACWMK
ADBBV
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADZKW
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFKRA
AFLOW
AFNRJ
AFQWF
AFRAH
AFWTZ
AFZKB
AGAYW
AGDGC
AGGBP
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHKAY
AHMBA
AHSBF
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJDOV
AJRNO
AJZVZ
AKMHD
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMXSW
AMYLF
AOCGG
ARMRJ
ASPBG
AXYYD
AZFZN
B-.
BA0
BDATZ
BENPR
BGNMA
BPHCQ
BVXVI
CCPQU
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
EBD
EBLON
EBS
EIOEI
EJD
EPAXT
ESBYG
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GXS
HF~
HG5
HG6
HMCUK
HMJXF
HQYDN
HRMNR
HVGLF
HZ~
I09
IHE
IJ-
IKXTQ
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
JBSCW
JCJTX
JZLTJ
KDC
KOV
KPH
LAS
LLZTM
M1P
M4Y
MA-
N9A
NB0
NPVJJ
NQJWS
NU0
O93
O9G
O9I
O9J
OAM
P19
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R89
R9I
RHV
RNS
ROL
RPX
RRX
RSV
S16
S27
S3A
S3B
SAP
SBL
SBY
SDH
SDM
SHX
SISQX
SJYHP
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SZN
T13
TSG
TSK
TSV
TUC
U2A
U9L
UG4
UKHRP
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
YLTOR
Z45
Z7R
Z7U
Z7W
Z7Z
Z82
Z83
Z87
Z8M
Z8O
Z8Q
Z8T
Z8V
Z8W
Z91
ZMTXR
ZOVNA
~EX
-Y2
.55
2.D
28-
2P1
2VQ
3O-
3SX
3V.
53G
5QI
AACDK
AAEOY
AAJBT
AANXM
AAQLM
AARHV
AASML
AAYTO
AAYZH
ABAKF
ABULA
ACAOD
ACBXY
ACDTI
ACZOJ
ADYPR
AEBTG
AEFIE
AEFQL
AEKMD
AEMSY
AFEXP
AFGCZ
AGGDS
AGJBK
AGQEE
AGRTI
AIGIU
AJBLW
ALIPV
BBWZM
CAG
COF
EMB
EMOBN
EN4
H13
KOW
N2Q
NDZJH
NPM
O9-
RIG
RNI
RZK
S1Z
S26
S28
SCLPG
SV3
T16
WK6
X7M
AAYXX
CITATION
7TK
7XB
8FK
K9.
PQEST
PQUKI
PRINS
7X8
ID FETCH-LOGICAL-c375t-fff8b851bc151ed6ca2ed967e0904e186e5021c3a430958cbba5ce8aa60c8dcc3
IEDL.DBID AEJHL
ISSN 0946-2716
IngestDate Fri Oct 25 02:29:22 EDT 2024
Mon Nov 04 11:55:49 EST 2024
Fri Nov 22 00:41:39 EST 2024
Wed Oct 16 00:46:57 EDT 2024
Sat Dec 16 11:59:53 EST 2023
IsPeerReviewed true
IsScholarly true
Issue 4
Keywords Beclin-1
FOXM1
Autophagy
LC3
Triple-negative breast cancer
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c375t-fff8b851bc151ed6ca2ed967e0904e186e5021c3a430958cbba5ce8aa60c8dcc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 30729279
PQID 2177016754
PQPubID 48876
PageCount 18
ParticipantIDs proquest_miscellaneous_2200772267
proquest_journals_2177016754
crossref_primary_10_1007_s00109_019_01750_8
pubmed_primary_30729279
springer_journals_10_1007_s00109_019_01750_8
PublicationCentury 2000
PublicationDate 2019-04-01
PublicationDateYYYYMMDD 2019-04-01
PublicationDate_xml – month: 04
  year: 2019
  text: 2019-04-01
  day: 01
PublicationDecade 2010
PublicationPlace Berlin/Heidelberg
PublicationPlace_xml – name: Berlin/Heidelberg
– name: Germany
– name: New York
PublicationTitle Journal of molecular medicine (Berlin, Germany)
PublicationTitleAbbrev J Mol Med
PublicationTitleAlternate J Mol Med (Berl)
PublicationYear 2019
Publisher Springer Berlin Heidelberg
Springer Nature B.V
Publisher_xml – name: Springer Berlin Heidelberg
– name: Springer Nature B.V
References PaquetteMEl-HoujeiriLPauseAmTOR pathways in cancer and autophagyCancers (Basel)2018101E1810.3390/cancers100100181:CAS:528:DC%2BC1cXisFKktrbI
SabaRAlsayedAZacnyJPDudekAZThe role of Forkhead box protein M1 in breast cancer progression and resistance to therapyInt J Breast Cancer201620161810.1155/2016/97681831:CAS:528:DC%2BC1cXnvFyjt7Y%3D
ZhouYRuckerEB3rdZhouBPAutophagy regulation in the development and treatment of breast cancerActa Biochim Biophys Sin Shanghai20164860741:CAS:528:DC%2BC1cXhtVOktr0%3D26637829
GartelALFOXM1 in cancer: interactions and vulnerabilitiesCancer Res2017773135313910.1158/0008-5472.CAN-16-35661:CAS:528:DC%2BC2sXhtVSqu7vF285841825519300
TekedereliIAlpaySNTavaresCDCobanogluZEKaoudTSSahinISoodAKLopez-BeresteinGDalbyKNOzpolatBTargeted silencing of elongation factor 2 kinase suppresses growth and sensitizes tumors to doxorubicin in an orthotopic model of breast cancerPLoS One20127e4117110.1371/journal.pone.00411711:CAS:528:DC%2BC38XhtFSkt73P229117543401164
ParmerTGWardMDYurkowEJVyasVHKearneyTJHaitWNActivity and regulation by growth factors of calmodulin-dependent protein kinase III (elongation factor 2-kinase) in human breast cancerBr J Cancer199979596410.1038/sj.bjc.66900121:CAS:528:DyaK1MXmvVKltQ%3D%3D104086942362180
BarsottiAMPrivesCPro-proliferative FoxM1 is a target of p53- mediated repressionOncogene2009284295430510.1038/onc.2009.2821:CAS:528:DC%2BD1MXhtFaju73P197497942898139
ZhongSZhouAQiFLiZYuZLuYLiuXDownregulating forkhead box M1 inhibits proliferation by inhibiting autophagy in the sw480 cell lineBiomed Rep20177475010.3892/br.2017.9151:CAS:528:DC%2BC1MXps1yrtA%3D%3D286850595492723
LeeYKLeeJARole of the mammalian ATG8/LC3 family in autophagy: differential and compensatory roles in the spatiotemporal regulation of autophagyBMB Rep20164942443010.5483/BMBRep.2016.49.8.0811:CAS:528:DC%2BC28XhvFyqtrrK274182835070729
WangICChenYJHughesDPetrovicVMajorMLParkHJTanYAckersonTCostaRHForkhead box M1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligaseMol Cell Biol200525108751089410.1128/MCB.25.24.10875-10894.20051:CAS:528:DC%2BD2MXhtlektr%2FO163145121316960
MizushimaNThe exponential growth of autophagy-related research: from the humble yeast to the Nobel prizeFEBS Lett201759168168910.1002/1873-3468.125941:CAS:528:DC%2BC2sXjsVSgtLc%3D28186333
KlionskyDJAbdelmohsenKAbeAAbedinMJAbeliovichHAcevedo ArozenaAAdachiHAdamsCMAdamsPDAdeliKAdhihettyPJAdlerSGAgamGAgarwalRAghiMKAgnelloMAgostinisPAguilarPVAguirre-GhisoJAiroldiEMAit-Si-AliSGuidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)Autophagy201612122210.1080/15548627.2015.11003562679965226799652
LuXFZengLiangWQChenCFSunSMLinHYFoxM1 is a promising candidate target in the treatment of breast cancerOncotarget2018984285229416660
TekedereliIAlpaySNAkarUYucaEAyugo-RodriguezCHanHDSoodAKLopez-BeresteinGOzpolatBTherapeutic silencing of Bcl-2 by systemically administered siRNA Nanotherapeutics inhibits tumor growth by autophagy and apoptosis and enhances the efficacy of chemotherapy in orthotopic xenograft models of ER (−) and ER (+) breast CancerMol Ther Nucleic Acids20132e12110.1038/mtna.2013.451:CAS:528:DC%2BC3sXhsF2ks7bI240220534028016
ZhangJWangGZhouYChenYOuyangLLiuBMechanisms of autophagy and relevant small-molecule compounds for targeted cancer therapyCell Mol Life Sci2018751803182610.1007/s00018-018-2759-21:CAS:528:DC%2BC1cXisVKjtbY%3D29417176
HamurcuZAshourAKahramanNOzpolatBFOXM1 regulates expression of eukaryotic elongation factor 2 kinase and promotes proliferation, invasion and tumorgenesis of human triple negative breast cancer cellsOncotarget20167166191663510.18632/oncotarget.7672269186064941339
YangHWenLWenMLiuTZhaoLWuBYunYLiuWWangHWangYWenNFoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-met/AKT-dependent positive feedback loopAnti-Cancer Drugs20182921622610.1097/CAD.00000000000005641:CAS:528:DC%2BC2sXhvFOitb%2FF293606625821477
KatohMIgarashiMFukudaHNakagamaHKatohMCancer genetics and genomics of human FOX family genesCancer Lett201332819820610.1016/j.canlet.2012.09.0171:CAS:528:DC%2BC38Xhs1agsLzE23022474
CazzanigaMEAiroldiMArcangeliVArtaleSAtzoriFBallerioAon behalf of; EVA Study GroupEfficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2-) advanced breast cancer patients: new insights beyond clinical trials. The EVA studyBreast20173511512110.1016/j.breast.2017.06.0431:STN:280:DC%2BC1cjnvFOktQ%3D%3D28711793
AbbaMCLacunzaEButtiMAldazCMBreast cancer biomarker discovery in the functional genomic age: a systematic review of 42 gene expression signaturesBiomark Insights201027103118
HamurcuZDelibaşıNGeçeneSŞenerEFDönmez-AltuntaşHÖzkulYCanatanHOzpolatBTargeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of cyclin-D1 and uPAR/integrin β1/ Src signaling in triple negative breast cancer cellsJ Cancer Res Clin Oncol201814441543010.1007/s00432-017-2557-51:CAS:528:DC%2BC1cXhvVGrtQ%3D%3D29288363
HamurcuZKahramanNAshourAOzpolatBFOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancerBreast Cancer Res Treat201716348549310.1007/s10549-017-4207-71:CAS:528:DC%2BC2sXltl2gtrY%3D28361350
LeungTWLinSSTsangACTongCSChingJCLeungWYOver-expression of FoxM1 stimulates cyclin B1 expressionFEBS Lett2001507596610.1016/S0014-5793(01)02915-51:CAS:528:DC%2BD3MXnslWrt7o%3D11682060
MiyashitaAFukushimaSNakaharaSYamashitaJTokuzumiAAoiJIchiharaAKanemaruHJinninMIhnHInvestigation of FOXM1 as a potential new target for melanomaPLoS One201510e014424110.1371/journal.pone.01442411:CAS:528:DC%2BC28XhsF2rsLk%3D266409504671728
AhmadAWangZKongDAliSLiYBanerjeeSAliRSarkarFHRetraction note to: FoxM1 down-regulation leads to inhibition of proliferation, migration and invasion of breast cancer cells through the modulation of extra-cellular matrix degrading factorsBreast Cancer Res Treat201615860710.1007/s10549-016-3904-y27412558
GartelATargeting FOXM1 auto-regulation in cancerCancer Biol Ther20151618518610.4161/15384047.2014.9875661:CAS:528:DC%2BC2MXhvVWqtL7L256034264622879
YeXZhangYHeBMengYLiYGaoYQuantitative proteomic analysis identifies new effectors of FOXM1 involved in breast cancer cell migrationInt J Clin Exp Pathol2015815836158441:CAS:528:DC%2BC1cXnslansr0%3D268848544730067
SongXFiati KenstonSSZhaoJYangDGuYRoles of FoxM1 in cell regulation and breast cancer targeting therapyMed Oncol2017344110.1007/s12032-017-0888-31:CAS:528:DC%2BC2sXitlKqtr4%3D28176242
ZhaoHYangMZhaoJWangJZhangYZhangQHigh expression of LC3B is associated with progression and poor outcome in triple-negative breast cancerMed Oncol20133047510.1007/s12032-013-0475-11:CAS:528:DC%2BC3sXjsVylur8%3D23371253
LefortSJoffreCKiefferYGivelAMBourachotBZagoGBiecheIDuboisTMeseureDVincent-SalomonACamonisJMechta-GrigoriouFInhibition of autophagy as a new means of improving chemotherapy efficiency in high-LC3B triple-negative breast cancersAutophagy2014102122214210.4161/15548627.2014.9817881:CAS:528:DC%2BC2MXmtlSns7o%3D25427136
EngebraatenOVollanHKMBørresen-DaleALTriple-negative breast cancer and the need for new therapeutic targetsAm J Pathol20131831064107410.1016/j.ajpath.2013.05.0331:CAS:528:DC%2BC3sXhsV2ktrjP23920327
The Cancer Genome Atlas NetworkComprehensive molecular portraits of human breast tumoursNature2013490617010.1038/nature11412
WierstraIThe transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological rolesAdv Cancer Res20131189739810.1016/B978-0-12-407173-5.00004-21:CAS:528:DC%2BC3sXhtlSqurzJ23768511
SunDZhuLZhaoYJiangYChenLYuYOuyangLFluoxetine induces autophagic cell death via eEF2K-AMPK-mTOR-ULK complex axis in triple negative breast cancerCell Prolif201851e1240210.1111/cpr.124021:CAS:528:DC%2BC1cXlvFGqtL4%3D29094413
NarrandesSHuangSMurphyLXuWThe exploration of contrasting pathways in triple negative breast cancer (TNBC)BMC Cancer2018182210.1186/s12885-017-3939-41:CAS:528:DC%2BC1cXisFWnu77F293015065753474
DengQWangZWangLZhangLXiangXWangZChongTLower mRNA and protein expression levels of LC3 and Beclin1, markers of autophagy, were correlated with progression of renal clear cell carcinomaJpn J Clin Oncol2013431261126810.1093/jjco/hyt16024186908
KusuzakiKMatsubaraTSatonakaHMatsumineANakamuraTSudoAMurataHHosogiSBaldiniNIntraoperative photodynamic surgery (iPDS) with Acridine Orange for musculoskeletal sarcomasCureus20146e204
CivilettoGDoganSACeruttiRFagiolariGMoggioMLampertiCBenincáCViscomiCZevianiMRapamycin rescues mitochondrial myopathy via coordinated activation of autophagy and lysosomal biogenesisEMBO Mol Med20181011e879910.15252/emmm.2017087991:CAS:528:DC%2BC1cXhvV2jur7F303098556220341
TangDYEllisRALovatPEPrognostic impact of autophagy biomarkers for cutaneous melanomaFront Oncol2016623610.3389/fonc.2016.00236278823085101199eCollection
YangXShiYYanJFanHDownregulation of FoxM1 inhibits cell growth and migration and invasion in bladder cancer cellsAm J Transl Res2018106296381:CAS:528:DC%2BC1MXhtlOku77F295114575835828
Nandi D, Cheema PS, Jaiswal N, Nag A (2017) FoxM1: repurposing an oncogene as a biomarker. Semin Cancer Biol. https://doi.org/10.1016/j.semcancer
ZhuHYangXLiuJZhouLZhangCXuLQinQZhanLLuJChengHSunXEukaryotic elongation factor 2 kinase confers tolerance to stress conditions in cancer cellsCell Stress Chaperones20152021722010.1007/s12192-014-0545-01:CAS:528:DC%2BC2cXhs1Ohsr3L25248493
WangXXieJChristopherGProud. Eukaryotic elongation factor 2 kinase (eEF2K) in cancerCancers (Basel)2017916210.3390/cancers91201621:CAS:528:DC%2BC1cXisV2isrjO
MrakovcicMFröhlichLFp53-mediated molecular control of autophagy in tumor cellsBiomolecules20188E1410.3390/biom80200141:CAS:528:DC%2BC1cXhvFWmsb7N29561758
DreosRAmbrosiniGPérierRCBucherPThe eukaryotic promoter database: expansion of EPDnew and new promoter analysis t
Z Hamurcu (1750_CR21) 2017; 163
I Tekedereli (1750_CR42) 2012; 7
I Dikic (1750_CR47) 2018; 19
X Wang (1750_CR20) 2017; 9
JJ Lee (1750_CR30) 2016; 97
1750_CR44
S Narrandes (1750_CR2) 2018; 18
G Civiletto (1750_CR29) 2018; 10
R Saba (1750_CR50) 2016; 2016
W Guo (1750_CR4) 2017; 22
A Ahmad (1750_CR13) 2016; 158
XF Lu (1750_CR8) 2018; 9
R Dreos (1750_CR25) 2014; 43
X Yang (1750_CR10) 2018; 10
Y Zhou (1750_CR16) 2016; 48
AL Gartel (1750_CR46) 2017; 77
Z Hamurcu (1750_CR14) 2016; 7
BY Fei (1750_CR12) 2017; 14
H Zhu (1750_CR26) 2015; 20
N Mizushima (1750_CR17) 2017; 591
B Ozpolat (1750_CR15) 2015; 7
Z Hamurcu (1750_CR19) 2018; 144
DJ Klionsky (1750_CR31) 2016; 12
TW Leung (1750_CR34) 2001; 507
H Yang (1750_CR11) 2018; 29
The Cancer Genome Atlas Network (1750_CR7) 2013; 490
I Tekedereli (1750_CR24) 2013; 2
MC Abba (1750_CR6) 2010; 27
S Lefort (1750_CR43) 2014; 10
AM Barsotti (1750_CR33) 2009; 28
I Wierstra (1750_CR37) 2013; 118
DY Tang (1750_CR18) 2016; 6
M Katoh (1750_CR36) 2013; 328
H Zhao (1750_CR38) 2013; 30
ME Cazzaniga (1750_CR3) 2017; 35
O Engebraaten (1750_CR5) 2013; 183
M Mrakovcic (1750_CR48) 2018; 8
TG Parmer (1750_CR27) 1999; 79
S Zhong (1750_CR40) 2017; 7
A Gartel (1750_CR45) 2015; 16
X Song (1750_CR9) 2017; 34
M Paquette (1750_CR28) 2018; 10
K Kusuzaki (1750_CR23) 2014; 6
IC Wang (1750_CR35) 2005; 25
A Miyashita (1750_CR51) 2015; 10
1750_CR1
X Ye (1750_CR32) 2015; 8
J Choi (1750_CR39) 2013; 62
D Sun (1750_CR41) 2018; 51
YK Lee (1750_CR49) 2016; 49
J Zhang (1750_CR52) 2018; 75
Q Deng (1750_CR22) 2013; 43
References_xml – volume: 18
  start-page: 22
  year: 2018
  ident: 1750_CR2
  publication-title: BMC Cancer
  doi: 10.1186/s12885-017-3939-4
  contributor:
    fullname: S Narrandes
– volume: 10
  start-page: e8799
  issue: 11
  year: 2018
  ident: 1750_CR29
  publication-title: EMBO Mol Med
  doi: 10.15252/emmm.201708799
  contributor:
    fullname: G Civiletto
– volume: 75
  start-page: 1803
  year: 2018
  ident: 1750_CR52
  publication-title: Cell Mol Life Sci
  doi: 10.1007/s00018-018-2759-2
  contributor:
    fullname: J Zhang
– volume: 163
  start-page: 485
  year: 2017
  ident: 1750_CR21
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-017-4207-7
  contributor:
    fullname: Z Hamurcu
– volume: 49
  start-page: 424
  year: 2016
  ident: 1750_CR49
  publication-title: BMB Rep
  doi: 10.5483/BMBRep.2016.49.8.081
  contributor:
    fullname: YK Lee
– volume: 48
  start-page: 60
  year: 2016
  ident: 1750_CR16
  publication-title: Acta Biochim Biophys Sin Shanghai
  doi: 10.1093/abbs/gmv119
  contributor:
    fullname: Y Zhou
– volume: 97
  start-page: 170
  year: 2016
  ident: 1750_CR30
  publication-title: Int J Exp Pathol
  doi: 10.1111/iep.12187
  contributor:
    fullname: JJ Lee
– volume: 6
  start-page: e204
  year: 2014
  ident: 1750_CR23
  publication-title: Cureus
  contributor:
    fullname: K Kusuzaki
– volume: 12
  start-page: 1
  year: 2016
  ident: 1750_CR31
  publication-title: Autophagy
  doi: 10.1080/15548627.2015.1100356
  contributor:
    fullname: DJ Klionsky
– volume: 7
  start-page: 47
  year: 2017
  ident: 1750_CR40
  publication-title: Biomed Rep
  doi: 10.3892/br.2017.915
  contributor:
    fullname: S Zhong
– ident: 1750_CR1
– volume: 591
  start-page: 681
  year: 2017
  ident: 1750_CR17
  publication-title: FEBS Lett
  doi: 10.1002/1873-3468.12594
  contributor:
    fullname: N Mizushima
– volume: 25
  start-page: 10875
  year: 2005
  ident: 1750_CR35
  publication-title: Mol Cell Biol
  doi: 10.1128/MCB.25.24.10875-10894.2005
  contributor:
    fullname: IC Wang
– volume: 507
  start-page: 59
  year: 2001
  ident: 1750_CR34
  publication-title: FEBS Lett
  doi: 10.1016/S0014-5793(01)02915-5
  contributor:
    fullname: TW Leung
– volume: 7
  start-page: 291
  year: 2015
  ident: 1750_CR15
  publication-title: Cancer Manag Res
  doi: 10.2147/CMAR.S34859
  contributor:
    fullname: B Ozpolat
– volume: 118
  start-page: 97
  year: 2013
  ident: 1750_CR37
  publication-title: Adv Cancer Res
  doi: 10.1016/B978-0-12-407173-5.00004-2
  contributor:
    fullname: I Wierstra
– volume: 43
  start-page: 1261
  year: 2013
  ident: 1750_CR22
  publication-title: Jpn J Clin Oncol
  doi: 10.1093/jjco/hyt160
  contributor:
    fullname: Q Deng
– volume: 19
  start-page: 349
  year: 2018
  ident: 1750_CR47
  publication-title: Nat Rev Mol Cell Biol
  doi: 10.1038/s41580-018-0003-4
  contributor:
    fullname: I Dikic
– ident: 1750_CR44
  doi: 10.1016/j.semcancer
– volume: 7
  start-page: e41171
  year: 2012
  ident: 1750_CR42
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0041171
  contributor:
    fullname: I Tekedereli
– volume: 27
  start-page: 103
  year: 2010
  ident: 1750_CR6
  publication-title: Biomark Insights
  contributor:
    fullname: MC Abba
– volume: 9
  start-page: 162
  year: 2017
  ident: 1750_CR20
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers9120162
  contributor:
    fullname: X Wang
– volume: 6
  start-page: 236
  year: 2016
  ident: 1750_CR18
  publication-title: Front Oncol
  doi: 10.3389/fonc.2016.00236
  contributor:
    fullname: DY Tang
– volume: 8
  start-page: 15836
  year: 2015
  ident: 1750_CR32
  publication-title: Int J Clin Exp Pathol
  contributor:
    fullname: X Ye
– volume: 28
  start-page: 4295
  year: 2009
  ident: 1750_CR33
  publication-title: Oncogene
  doi: 10.1038/onc.2009.282
  contributor:
    fullname: AM Barsotti
– volume: 490
  start-page: 61
  year: 2013
  ident: 1750_CR7
  publication-title: Nature
  doi: 10.1038/nature11412
  contributor:
    fullname: The Cancer Genome Atlas Network
– volume: 30
  start-page: 475
  year: 2013
  ident: 1750_CR38
  publication-title: Med Oncol
  doi: 10.1007/s12032-013-0475-1
  contributor:
    fullname: H Zhao
– volume: 35
  start-page: 115
  year: 2017
  ident: 1750_CR3
  publication-title: Breast
  doi: 10.1016/j.breast.2017.06.043
  contributor:
    fullname: ME Cazzaniga
– volume: 158
  start-page: 607
  year: 2016
  ident: 1750_CR13
  publication-title: Breast Cancer Res Treat
  doi: 10.1007/s10549-016-3904-y
  contributor:
    fullname: A Ahmad
– volume: 34
  start-page: 41
  year: 2017
  ident: 1750_CR9
  publication-title: Med Oncol
  doi: 10.1007/s12032-017-0888-3
  contributor:
    fullname: X Song
– volume: 8
  start-page: E14
  year: 2018
  ident: 1750_CR48
  publication-title: Biomolecules
  doi: 10.3390/biom8020014
  contributor:
    fullname: M Mrakovcic
– volume: 62
  start-page: 275
  year: 2013
  ident: 1750_CR39
  publication-title: Histopathology
  doi: 10.1111/his.12002
  contributor:
    fullname: J Choi
– volume: 51
  start-page: e12402
  year: 2018
  ident: 1750_CR41
  publication-title: Cell Prolif
  doi: 10.1111/cpr.12402
  contributor:
    fullname: D Sun
– volume: 20
  start-page: 217
  year: 2015
  ident: 1750_CR26
  publication-title: Cell Stress Chaperones
  doi: 10.1007/s12192-014-0545-0
  contributor:
    fullname: H Zhu
– volume: 7
  start-page: 16619
  year: 2016
  ident: 1750_CR14
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.7672
  contributor:
    fullname: Z Hamurcu
– volume: 22
  start-page: 427
  year: 2017
  ident: 1750_CR4
  publication-title: Crit Rev Oncog
  doi: 10.1615/CritRevOncog.2017020575
  contributor:
    fullname: W Guo
– volume: 328
  start-page: 198
  year: 2013
  ident: 1750_CR36
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2012.09.017
  contributor:
    fullname: M Katoh
– volume: 14
  start-page: 6553
  year: 2017
  ident: 1750_CR12
  publication-title: Oncol Lett
  contributor:
    fullname: BY Fei
– volume: 10
  start-page: E18
  issue: 1
  year: 2018
  ident: 1750_CR28
  publication-title: Cancers (Basel)
  doi: 10.3390/cancers10010018
  contributor:
    fullname: M Paquette
– volume: 10
  start-page: 629
  year: 2018
  ident: 1750_CR10
  publication-title: Am J Transl Res
  contributor:
    fullname: X Yang
– volume: 2016
  start-page: 1
  year: 2016
  ident: 1750_CR50
  publication-title: Int J Breast Cancer
  doi: 10.1155/2016/9768183
  contributor:
    fullname: R Saba
– volume: 10
  start-page: 2122
  year: 2014
  ident: 1750_CR43
  publication-title: Autophagy
  doi: 10.4161/15548627.2014.981788
  contributor:
    fullname: S Lefort
– volume: 77
  start-page: 3135
  year: 2017
  ident: 1750_CR46
  publication-title: Cancer Res
  doi: 10.1158/0008-5472.CAN-16-3566
  contributor:
    fullname: AL Gartel
– volume: 10
  start-page: e0144241
  year: 2015
  ident: 1750_CR51
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0144241
  contributor:
    fullname: A Miyashita
– volume: 43
  start-page: D92
  issue: Database issue
  year: 2014
  ident: 1750_CR25
  publication-title: Nucleic Acids Res
  contributor:
    fullname: R Dreos
– volume: 79
  start-page: 59
  year: 1999
  ident: 1750_CR27
  publication-title: Br J Cancer
  doi: 10.1038/sj.bjc.6690012
  contributor:
    fullname: TG Parmer
– volume: 183
  start-page: 1064
  year: 2013
  ident: 1750_CR5
  publication-title: Am J Pathol
  doi: 10.1016/j.ajpath.2013.05.033
  contributor:
    fullname: O Engebraaten
– volume: 29
  start-page: 216
  year: 2018
  ident: 1750_CR11
  publication-title: Anti-Cancer Drugs
  doi: 10.1097/CAD.0000000000000564
  contributor:
    fullname: H Yang
– volume: 16
  start-page: 185
  year: 2015
  ident: 1750_CR45
  publication-title: Cancer Biol Ther
  doi: 10.4161/15384047.2014.987566
  contributor:
    fullname: A Gartel
– volume: 144
  start-page: 415
  year: 2018
  ident: 1750_CR19
  publication-title: J Cancer Res Clin Oncol
  doi: 10.1007/s00432-017-2557-5
  contributor:
    fullname: Z Hamurcu
– volume: 2
  start-page: e121
  year: 2013
  ident: 1750_CR24
  publication-title: Mol Ther Nucleic Acids
  doi: 10.1038/mtna.2013.45
  contributor:
    fullname: I Tekedereli
– volume: 9
  start-page: 842
  year: 2018
  ident: 1750_CR8
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.23182
  contributor:
    fullname: XF Lu
SSID ssj0017594
Score 2.5154145
Snippet Triple-negative breast cancer (TNBC) is associated with poor prognosis owing to its aggressive and heterogeneous nature, and the lack of therapeutic targets....
SourceID proquest
crossref
pubmed
springer
SourceType Aggregation Database
Index Database
Publisher
StartPage 491
SubjectTerms Autophagy
Biomedical and Life Sciences
Biomedicine
Breast cancer
Cell survival
Chromatin
Clinical trials
Drug resistance
Forkhead protein
Human Genetics
Immunoprecipitation
Internal Medicine
Medical prognosis
Molecular Medicine
Molecular modelling
Original Article
Phagocytosis
Proteins
Rapamycin
Starvation
Therapeutic applications
Transcription
Tumorigenesis
Title FOXM1 plays a role in autophagy by transcriptionally regulating Beclin-1 and LC3 genes in human triple-negative breast cancer cells
URI https://link.springer.com/article/10.1007/s00109-019-01750-8
https://www.ncbi.nlm.nih.gov/pubmed/30729279
https://www.proquest.com/docview/2177016754
https://search.proquest.com/docview/2200772267
Volume 97
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnR3LbtNAcNSHVHEBSnkYWjRI3GBR4n05x1ISAmrhQCv1Zq13N1FF5FZ5HHLmx5nZ2Eao5UAPlg9ej9c7s_PYeQG8JZowQUstYu6UUJoMlIoDbJQxIXeEdZWq7Y9_2G-Xxachl8mR3dFF_fND65FMjLrLdUtOHLJ8-SIxJ4pt2CXZo4m4d4-HX8ennfPA6tT_kAwXI3KyB5pcmbuh_C2PbimZtxykSe6MHt1rxo_hYaNm4vGGLvZhK9ZPYO-scaQfwK_R98uzPt7M3HqBDjnGEK9qdCuuM-Cma6zWuGQx1jIVN5utcb5pXE-TwI-RcypFH10d8PRE4pSZJsNIXf_oZT7BF3WcpsriWHHw-xI9E9kc2V2weAoXo-H5yVg0_RiEl1YvxWQyKSrS0CpPakIMxrs8hoGxsTfoqdgvTNSkMXjplCTFrfBV5bSPhXOm54vgvXwGO_V1HV8A5hNaFmIXpB4GZSs5UN6HaPJIHIHEtszgXYuV8mZTdqPsCiyndS0JQJnWtSwyOGwRVzZbcFGSrWU5x0KrDN50j2nz8C-6Ol6vaAyf1FrSQG0GzzcI7z4nuaZ6bgcZvG_R-wf4v-fy8v-Gv4IHeaIQjgU6hJ3lfBWPYHsRVq8bsub7l_PPo9-v5fCa
link.rule.ids 315,782,786,27933,27934,41073,42142,48344,48347,48357,49649,49652,49662,52153
linkProvider Springer Nature
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB7RVoJeeJeGFhgkbmBpN3bs5NiWLluxWw4sUm-RY3tXSKu02sdhz_3jnfEmQahwgENOSRzHM575xvMC-EA8oX0mMxFSq4TKyECpOMBGae1TS1RXsdr-8Lu5vMo_n3OZHNXmwsRo99YlGSV1l-wWvThk-vJFek7kO7CnCq2Il_dOLiZfBp33wGSxASJZLlqkZBA0yTJ_HuV3hXQPZd7zkEbFM3jyf1N-Co8boIknW854Bg9C_RwejhtX-gu4HXy7GvfxZm43S7TIUYb4s0a75koDdrbBaoMrVmStWLHz-QYX29b1NAk8DZxVKfpoa4-jM4kzFps8Ruz7Ry_zGb6owyzWFseKw99X6JjNFsgOg-VL-DE4n5wNRdORQThpspWYTqd5RRitcgQUgtfOpsEX2oRe0VOhn-uQEWZw0ipJ0C13VWUzF3Jrdc_l3jl5ALv1dR0OAdMpLQsJDAKIXplKFso5H3QaSCaQ4pYJfGzJUt5sC2-UXYnluK4lDVDGdS3zBI5bypXNJlyWZG0ZzrLIVALvu9u0ffgXbR2u1_QMn9UawqAmgVdbinefk1xVPTVFAp9a8v4a_O9zef1vj7-DR8PJeFSOLi6_HsF-GrmFI4OOYXe1WIc3sLP067cNj98Bld_y_A
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Lb9QwEB7RVqq4QGmhDbTUlXoDq7uxY2ePfexqC9uCBEi9RY7trCqt0tVu9rBn_jgzzgOhwqHikFOSieMZe77xvABOUSaUS0TCfWwklwkaKDkF2EilXGyQ6zJU2x9_07d36dWQyuR0Wfwh2r11SdY5DVSlqazO5q446xLfgkcHzWC6UOfxdAO2JFoyKOlb58NP40nnSdBJaIaIVoziMRoHTeLM36n8qZweIc5H3tKghEYv_3_4O_CiAaDsvJaYV_DMl7uwfdO42Pfg5-jL3U2fzWdmvWSGUfQhuy-ZWVEFAjNds3zNKlJw7XZjZrM1W9Qt7XFA7MJTtiXvM1M6NrkUbErbKdEI_QDxZTrb56WfhprjLKew-IpZEr8FI0fC8jX8GA2_X45506mBW6GTihdFkeaI3XKLAMI7ZU3s3UBp3xv0pO-nyieIJawwUiCkS22em8T61BjVs6mzVryBzfKh9AfA4gKnBTcSBI5O6lwMpLXOq9jjXoEKXUTwoWVRNq8LcmRd6eUwrxkSyMK8ZmkEhy0Xs2ZxLjO0wjRlXyQygpPuNi4r-kVT-ocVPkNnuBqxqY5gv-Z-9zlB1dZjPYjgY8vq38T_PZa3T3v8GLa_Xo2yyfXt53fwPA7CQgFDh7BZLVb-CDaWbvW-EfdfuDT7vw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=FOXM1+plays+a+role+in+autophagy+by+transcriptionally+regulating+Beclin-1+and+LC3+genes+in+human+triple-negative+breast+cancer+cells&rft.jtitle=Journal+of+molecular+medicine+%28Berlin%2C+Germany%29&rft.au=Hamurcu%2C+Zuhal&rft.au=Deliba%C5%9F%C4%B1%2C+Nesrin&rft.au=Nalbantoglu%2C+Ufuk&rft.au=Sener%2C+Elif+Funda&rft.date=2019-04-01&rft.pub=Springer+Berlin+Heidelberg&rft.issn=0946-2716&rft.eissn=1432-1440&rft.volume=97&rft.issue=4&rft.spage=491&rft.epage=508&rft_id=info:doi/10.1007%2Fs00109-019-01750-8&rft.externalDocID=10_1007_s00109_019_01750_8
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0946-2716&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0946-2716&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0946-2716&client=summon